QA: Iterum Therapeutics plc in us_pharma/2022

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001659323_2023_Iterum_Therapeutics_plc.pdf

Logs

info NetIncome node detected by tax heuristic input.sec.calculation_linkbase.edgar_model_mapping {'net_inc_node': 'NetIncomeLossAvailableToCommonStockholdersBasic'}

Graph

Absolute values for 0001659323, Iterum Therapeutics plc

  xvar xval
0 AssetsCurrent 62,444,000
1 IntangibleAssetsNetIncludingGoodwill 1,719,000
2 PropertyPlantAndEquipmentNet 69,000
3 remainder_Assets 2,601,000
4 LiabilitiesCurrent 9,064,000
5 LiabilitiesNoncurrent 11,398,000
6 remainder_Liabilities 18,372,000
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 12,766,000
9 ResearchAndDevelopmentExpense 17,617,000
10 remainder_Expenses 301,000
11 remainder_Revenues 0
12 remainder_NetIncome -13,750,000
13 remainder_ComprehensiveNetIncome -350,000
  yvar yval
0 Assets 66,833,000
1 Liabilities 38,834,000
2 Expenses 30,684,000
3 Revenues 0
4 StockholdersEquity 27,999,000
5 NetIncome -44,434,000
6 ComprehensiveNetIncome -44,609,000
7 BaseVar 75,225,500
8 EconomicCapitalRatio 0.0672

Edgar->Model Mapping

Feature Distribution

Change over Time